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Running title: Triadin KO mouse
 
Triadin is a multiple proteins family, some 
isoforms being involved in muscle excitation-
contraction coupling, and some having still 
unknown functions. In order to obtain clues 
on triadin functions, we engineered a triadin 
knock out mouse line, and characterized the 
physiological effect of triadin ablation on 
skeletal muscle function. These mice 
presented a reduced muscle strength, which 
seemed not to alter their survival, and which 
has been characterized in the present work. 
We first checked in these mice the expression 
level of the different proteins involved in 
calcium homeostasis, and observed in fast 
muscles an increase in expression of 
dihydropyridine receptor, with a large 
reduction in calsequestrin expression. 
Electron microscopy analysis of KO muscles 
morphology demonstrated the presence of 
triads in abnormal orientation, and a 
reduction in the sarcoplasmic reticulum 
terminal cisternae volume. Using calcium 
imaging on cultured myotubes, we observed a 
reduction in the total amount of calcium 
stored in the sarcoplasmic reticulum. 
Physiological studies have been performed to 
evaluate the influence of triadin deletion on 
skeletal muscle function. Muscle strength has 
been measured both on whole animal, using 
hang test or electrical stimulation combined 
with NMR analysis and strength 
measurement, or on isolated muscle using 
electrical stimulation. All the results obtained 
demonstrate an important reduction in 
muscle strength, indicating that triadin plays 
an essential role in skeletal muscle function 
and in skeletal muscle structure. These results 
indicate that triadin alteration lead to the 
development of a myopathy, which could be 
studied using this new animal model. 
 
Muscle contraction is activated by Ca2+ release 
from the sarcoplasmic reticulum in response to 
plasma membrane depolarization. This process 
called excitation-contraction coupling (E-C 
coupling) takes place at the skeletal muscle triad 
junction, where T-tubules and the sarcoplasmic 
reticulum terminal cisternae are in close contact 
[1]. Calcium release occurs via the calcium 
release complex, a macromolecular complex 
specifically localized in the skeletal muscle triad 
[2]. The main components of this calcium release 
complex are the ryanodine receptor (RyR) and 
the dihydropyridine receptor (DHPR) [3], both of 
which are calcium channels. It is now clear that a 
number of proteins are associated with these two 
calcium channels to form the calcium release 
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complex, among which triadin. Triadin is an 
integral membrane protein of the sarcoplasmic 
reticulum, first identified in rabbit skeletal 
muscle as a 95-kDa glycoprotein specifically 
located in the triads [4, 5]. Because of its co-
localization with RyR in the triads, involvement 
of triadin in excitation-contraction coupling has 
been postulated [6, 7]. Protein interaction studies 
have shown that the major molecular partners of 
triadin are RyR [8-10], calsequestrin (CSQ), the 
protein which traps calcium inside the 
sarcoplasmic reticulum [11-13], and junctin [14]. 
Functional studies have shown that triadin by 
itself regulates the activity of the RyR calcium 
channel in vitro [10, 15].  
Triadin is expressed in both cardiac and skeletal 
muscles. In cardiac muscle, several isoforms of 
triadin have been identified, the major one being 
CT1 (cardiac triadin 1) [16]. We have shown that 
at least 4 isoforms of triadin are expressed in rat 
skeletal muscle [17, 18]. All these isoforms are 
issued from the alternative splicing of the same 
gene [19]. We have previously reported that the 
major skeletal muscle triadin isoform is Trisk 51, 
both in rat and in human [18, 19]. Trisk 95, the 
"classical" 95kDa isoform, is expressed in almost 
equivalent amounts, and Trisk 32, the 32kDa 
isoform identical to CT1, represents 10-20% of 
all triadins [18, 20]. Overexpression studies 
using adenoviruses have shown that Trisk 95 is 
able to block the depolarization-induced calcium 
release, but in the same conditions, no effect was 
observed with Trisk 51 overexpression, and 
therefore no function could be attributed to this 
isoform [21]. Triadin knock-down has also been 
realized using siRNA in cultured cells [22, 23], 
and resulted in reduction of the depolarization-
induced calcium release. In addition to various 
functional effects resulting from expression 
modification, the triadin isoforms have different 
localizations and partners, and whereas Trisk 95 
and Trisk 51 are both located within the triad and 
are associated with RyR, Trisk 32 is mainly in 
the longitudinal sarcoplasmic reticulum 
associated to the inositol-trisphosphate receptor 
(IP3R) [18].  
Triadin has mainly been characterized on a 
molecular point of view, and only few 
physiological studies have been performed. In 
order to determine functions of triadin in the 
whole animal, we have engineered a mouse line 
deleted of all the triadin isoforms. After 
molecular characterization of the muscles of this 
mouse, we studied their morphology and 
function. Muscle function and muscle strength 
were studied both on whole animal and on 
isolated muscle, using hanging test or electrical 
stimulation combined with force measurement 
and MR imaging. All the results presented in this 
study confirmed an important reduction in 
muscle strength in triadin KO animals, and this 
mouse line could therefore represent a new 
animal model to study the development of a 
structural myopathy. 
 
Experimental procedures 
 
Engineering of the triadin KO mouse 
The Triadin conditional mutant mouse line 
(triadin flox), as well as the full triadin KO 
(triadin KO) mouse line were established at the 
MCI/ICS (Mouse Clinical Institute - Institut 
Clinique de la Souris-, Illkirch, France; 
http://www-mci.u-strasbg.fr). The targeting 
vector was constructed as follows: a 1.2 kb 
fragment corresponding to the floxed fragment 
(comprising the ATG containing exon 1) as well 
as the 3.7 kb 5’ homolog arm and 3.3 kb 3’ 
homolog arm were amplified by PCR and 
subsequently cloned into a MCI basic vector. 
This vector already contained the LoxP sites and 
the Neomycin resistance cassette flanked by frt 
sites, which was then excised after selection 
using flp. The coding region and the junctions 
were verified by sequencing. The linearized 
construct was electroporated in 129S2/SvPas 
mouse embryonic stem (ES) cells. After 
selection, targeted clones were identified by PCR 
using external primers and further confirmed by 
Southern blots with Neo and 3’ external probes. 
Three positive ES clones were obtained. One was 
microinjected into C57BL/6J blastocysts, and 
derived male chimaeras gave germline 
transmission. In order to generate full triadin KO 
mice, heterozygotes triadin flox mice were 
crossed with CMV Cre+/+ mice [24] expressing 
the Cre recombinase in the zygote, to generate 
heterozygous triadin KO mice (triadin +/-). These 
mice were crossed to generate WT (triadin+/+) 
and KO (triadin-/-) littermates used in the 
experiments described here. 
 
Antibodies and Western blot analysis 
Anti-calsequestrin monoclonal antibody (clone 
VIIID12) was obtained from Affinity 
BioReagents. Polyclonal antibody against RyR 
has been previously described [3], as well as 
antibodies against Trisk 95 and Trisk 51 [17], 
and antibodies against the N-terminal end of 
triadins [25]. An antibody against mouse Trisk 
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32 (C-terminal peptide: RRQQEVQRE) was 
produced as previously described [18]. Rabbit 
anti-bovine mitochondrial FoF1-ATPase antibody 
was previously characterized [26]. Rabbit anti 
junctin were from Santa Cruz (Santa Cruz 
Biotechnology, Inc). Rabbit anti-SERCA, kindly 
provided by Dr MJ Moutin, was produced by 
rabbit immunization with purified large 
cytoplasmic loop of the Ca2+-ATPase [27]. 
Secondary antibodies used for Western blot were 
labeled with HRP (Jackson ImmunoResearch 
Laboratories). 
The presence and the amount of different 
proteins in samples was assayed by Western blot 
analysis, using a chemiluminescent reagent 
(Western lightning Chemiluminescence reagent 
plus, Perkin Elmer) after electrophoretic 
separation of the protein on a 5-15% acrylamide 
gel, and electrotransfer on Immobilon P 
(Millipore) [17]. The quantification was 
performed using a ChemiDoc XRS apparatus 
(Biorad) and the Quantity One Software 
(Biorad). The signal was normalized to the 
amount of myosin, measured after staining of the 
membrane with Coomassie blue. 
 
Muscle fibres preparation and 
immunofluorescent labeling 
All procedures using animals were approved by 
the Institutional ethics committee and followed 
the guidelines of the National Research Council 
Guide for the care and use of laboratory animals. 
Flexor Digitorum Brevis (FDB) fibres were 
dissociated according to the procedure described 
by Pouvreau et al. [28]. Intact FDB were excised 
from the hind paw in Ringer-Glucose solution 
(136 mM NaCl, 10 mM Glucose, 5 mM KCl, 
2.6 mM CaCl2, 1 mM MgCl2, 10 mM Hepes 
pH7.2) and digested 30-45 min at 37°C in 
collagenase (2mg/ml in Ringer, Sigma Aldrich). 
Muscles were washed 10 min at room 
temperature and kept 2h at 4°C in 25ml Ringer. 
Fibres were then dissociated by several flushing 
and seeded on laminin coated slides 20 min at 
room temperature. Immunofluorescent labelling 
was performed using a protocol adapted from 
Vassilopoulos et al. [18]. Fibres were fixed for 
15 min with 4% paraformaldehyde in PBS at 
room temperature, permeabilized 5 min with 1% 
Triton X-100 in PBS at room temperature and 
saturated 30-min with PBS supplemented with 
0.1% TritonX-100, 0.5% bovine serum albumin, 
and 2% goat serum. Fibres were incubated 1 h at 
room temperature with the primary antibodies 
(dilution, 1:100 to 1:800) in PBS supplemented 
with 0.1% Triton X-100, 0.5% bovine serum 
albumin, and 2% goat serum and then incubated 
with secondary antibodies for 30 min at room 
temperature. The nuclei were stained with TO-
PRO-3 (Molecular Probes), and the samples 
were mounted with an anti-fading solution 
(DakoCytomation fluorescent mounting medium; 
DakoCytomation). For double labelling, the two 
primary antibodies (from different species) and 
the two secondary antibodies were added at the 
same time. The secondary antibodies were 
labelled with either Alexa-488, Alexa-546 (both 
from Molecular Probes), or Cy3 (Jackson 
ImmunoResearch Laboratories). Muscle fibres 
were analyzed by confocal laser scanning 
microscopy using a Leica SPE operating system, 
with sequential excitation of the two 
fluorophores.  
 
Electron microscopy 
Extensor Digitorum Longus (EDL) and soleus 
(Sol) muscles of 5-6 months old mice were 
excised and cut into small pieces. After 3 washes 
in Cacodylate buffer 0.1M, muscles were post-
fixed in 2.5% Glutaraldehyde, Cacodylate buffer 
0.1M 2h at 4°C. After 3 washes in Cacodylate 
buffer, T-tubules were stained in 1% OsO4, 
Cacodylate buffer 0.1M, 1h on ice. Muscles were 
washed 5 min in Cacodylate buffer 0.1M and 4 
times in H2O and then stained in 1% Uranyl 
Acetate pH4 4°C overnight. After dehydration 
with a graded series of alcohols and infiltrated in 
epoxy resin (Fluka), fibres were horizontally 
embedded in flat molds. For T-tubule staining 
(adaptation from Galbiati et al, [31]), 75mM of 
CaCl2 were added in the post-fixation solution 
and 0.4% K3Fe(CN)6 was also added in the OsO4 
solution and incubated for 2h at room 
temperature. 70nm section were cut from the 
blocks with the ultramicrotome Leica Ultracut S 
and post-stained for 10min at room temperature 
with 5% uranyl acetate pH4, washed four times 
in water, incubated 5min at room temperature in 
4% lead citrate and washed four times in water. 
The sections were observed with a JEOL JEM 
1200EX II at 60kV. 
 
Muscle homogenates preparation 
Two types of skeletal muscle i.e. extensor 
digitorum longus (EDL) and soleus (Sol) were 
collected from young (10 weeks) or adult (6-9 
months) mouse hind legs. Crude homogenates 
were prepared from each muscle by 
homogenization in 200 mM sucrose, 20 mM 
HEPES (pH = 7.4), 0.4 mM CaCl2, 2 mM 
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leupeptin, 100 mM PMSF, 1 mM DFP. The 
amount of total protein was estimated using a 
modified Folin assay in presence of SDS. 
 
Cell culture and intracellular calcium 
measurements  
Primary cultures of neonatal mouse skeletal 
muscle (WT and KO) were obtained as described 
previously [17]. Changes in intracellular calcium 
were measured on WT or KO 3-4 days primary 
myotubes, using the calcium-dependent 
fluorescent dye Fluo 4-AM (Molecular Probes), 
as described previously [21]. Calcium imaging 
was performed in Krebs buffer (NaCl 136 mM, 
KCl 5 mM, CaCl2 2 mM, MgCl2 1mM, HEPES 
10 mM pH 7.4). To obtain a calcium-free Krebs 
solution, CaCl2 was left out, while 1 mM EGTA, 
10 µM La3+ and 50µM Cd2+ were added. 
Thaspigargin (Molecular Probes) was diluted at 
1µM in this medium, and applied simultaneously 
with caffeine 40mM as decribed previously [29, 
30]. Fluorescence was measured by confocal 
laser scanning microscopy, using a Leica TCS-
SPE operating system, in the xyt mode. Data are 
given as mean ± SEM, and n represents the 
number of myotubes in each condition. 
 
Hang tests 
For the first test, animals (6 months old females) 
were placed on wires stretched between two 
poles 50 cm apart and were allowed to freely 
move along the wire. Each animal was tested 4 
or 5 times during a 7 days period, and all the 
tests were used for the statistical analysis. For the 
second test, animals (10 weeks and 6 months 
old) were positioned on a cross-wired surface 
where they could hold on with all four paws. The 
grid was then turn up side down. We measured 
the time during which animals were able to stay 
on wires before falling. The test was repeated 3 
times successively for each animal, and only the 
best score was used for the statistical analysis. 
After 5 min hanging (300s), the test was stopped. 
 
Isolated muscle contraction measurements 
Fast (EDL) or slow (Sol) twitch muscles, isolated 
from 6 months old females, were placed 
horizontally in an experimental chamber 
continuously superfused (10 ml.min-1) with 
Krebs’ solution (135 mM NaCl, 5 mM KCl, 2.5 
mM CaCl2, 1 mM MgSO4, 10 mM glucose, 10 
mM NaHCO3; 10 mM Hepes pH 7.2; room 
temperature) equilibrated with 95% O2 plus 5% 
CO2. 
One end of the muscle was attached to a rod 
while the other to a capacitive force transducer. 
Two platinum electrodes placed adjacent to the 
muscle were used to deliver short (1 ms), 
supramaximal pulses to elicit single twitches. 
Force responses were digitized at 2 kHz by using 
Digidata 1200 A/D card and stored with Axotape 
software (Axon Instruments, Foster City, CA, 
USA). Muscles were then stretched by adjusting 
the position of the transducer to a length that 
produced the maximal force response and 
allowed to equilibrate for 60 min. 
Single pulses (1Hz) were used to elicit single 
twitches. At least 10 twitches were measured 
under these conditions from each animal, and the 
averaged amplitude of all transients was used in 
order to characterize the given animal. Tetanic 
contraction was obtained by stimulation at 
200 Hz during 200 ms for EDL and at 100 Hz 
during 500 ms for Sol. 
 
Fatigue test on isolated muscle 
In order to test muscle fatigability a series of 
tetanic contraction (altogether 150) at a 
frequency of 0.5 Hz were evoked [32]. The 
amplitude of each tetanus was then normalized to 
that of the largest in the series (usually the first 
or the second) and plotted as a function of the 
position within the series. 
 
Animal preparation for NMR studies 
Nine WT and nine triadin KO 5 month old males 
were used for these experiments. For each 
animal, MR functional investigation was 
performed in the left gastrocnemius muscles. 
Mice were initially anesthetized in an induction 
chamber (Equipement Vétérinaire Minerve, 
France) using 4 % isoflurane (Forene; Abbot 
France, Rungis, France) in 33 % O2 and 66 % 
N2O. Once both lower hind limbs were shaved, 
the anesthetized animal was placed supine in a 
home-built cradle especially designed for a 
strictly non-invasive muscle investigation. This 
cradle integrates two rod-shaped transcutaneous 
electrodes (located above the knee and under the 
heel respectively) connected to an electrical 
stimulator (Stimulator I series, Hugo Sachs 
Elektronik, Harvard Apparatus, USA) and an 
ergometer consisting of a 9 x 24 mm foot pedal 
coupled to a force transducer. The transducer 
was constructed by sticking a strain gauge (ref. 
1-LY11-6/120A; HBM GmbH, Darmstadt, 
Germany) according to the manufacturer 
specifications on a 9 x 32 mm Bakelite slat (0.4-
mm thickness) in a Wheatstone bridge design. 
 by guest, on M
arch 29, 2010
w
w
w
.jbc.org
D
ow
nloaded from
 
 5
The foot was positioned on the ergometer pedal 
and the hind limb was immobilized in the cradle. 
In that position, the hind limb was centered 
inside a 20-mm-diameter 1H Helmholtz imaging 
coil and the belly of the gastrocnemius muscle 
was located above an elliptic 31P-MRS surface 
coil (8 x 12 mm). The pedal position was 
adjusted in order to modify the angle between the 
foot and the lower hind limb so that the 
gastrocnemius muscle was passively stretched at 
rest and produced a maximum isometric twitch 
tension in response to supramaximal square wave 
pulses (1.5 ms duration). Supra-maximal current 
(usually 2-4 mA) was determined by inducing 
contractions with increasing current. Throughout 
the experiment, anesthesia was maintained by 
gas inhalation with a facemask continuously 
supplied with 2.5 % isoflurane in 33 % O2 (0.4 
L/min) and 66 % N2O (0.8 L/min) and connected 
to an open-circuit gas anesthesia machine (Isotec 
3; Ohmeda Medical, Herts, UK). Animal body 
temperature was maintained through a feedback 
loop including an electrical heating blanket 
(Prang+Partner AG, Pfungen, Switzerland), a 
temperature control unit (ref 507137; Harvard 
Apparatus, Holliston, Massachusetts, USA) and a 
home-built rectal thermometer constructed with a 
NTC thermistor SMC series (ref: 
NCP18XW220J03RB-2.2K, Murata, Kyoto, 
Japan). 
 
Whole animal stimulation protocol and force 
measurements  
The transcutaneous stimulation protocol 
consisted in 6 min of repeated isometric 
contractions at a frequency of 1.7 Hz. Analog 
electrical signal coming out from the force 
transducer was amplified with a home-built 
amplifier (Operational amplifier AD620; Analog 
Devices, Norwood, MA, USA; gain = 70 dB; 
bandwidth 0–5 kHz) converted to a digital signal 
(PCI-6220; National Instrument, Austin, TX, 
USA) and recorded on a personal computer using 
the WinATS software version 6.5 (Sysma, Aix-
en-Provence, France). Isometric force production 
per twitch (in N) was averaged every 30 s and 
normalized to the MRI-calculated muscle 
volume. 
 
MR data acquisition and processing.  
Investigations were performed in a 4.7 Tesla 
horizontal magnet (47/30 Biospec Avance, 
Bruker, Karlsruhe, Germany) equipped with a 
Bruker 120-mm BGA12SL (200 mT/m) gradient 
insert. Ten non contiguous axial scout slices (1 
mm thickness, spaced 0.5 mm) covering the 
region from the knee to the ankle were selected 
across the lower hind limb. Multiecho images of 
these slices (8 echoes; 10.587-ms spaced; 1000-
ms repetition time; 42x42 mm2 field-of-view; 
256 x 256 acquisition matrix; 3.2-min acquisition 
time) were recorded at rest. 31P-MRS spectra (32 
scans, 8 kHz sweep width; 2048 data points) 
from the gastrocnemius region were 
continuously acquired in 60-s blocks throughout 
a standardized experimental protocol consisting 
in 6-min rest, 6-min stimulation and 16-min 
recovery. MR data acquisition was gated to 
muscle stimulation in order to reduce potential 
motion artifacts due to contraction. MR data 
were processed using a custom-written image 
analysis program developed on the IDL platform 
(Interactive Data Language, Research System, 
Inc., Boulder, CO, USA). For each MRI slice, 
gastrocnemius region was manually outlined in 
order to measure the corresponding cross-
sectional areas (CSA, in mm2). The 
gastrocnemius muscle volume (mm3) was 
calculated as the sum of volumes included 
between consecutive slices. PCr, inorganic 
phosphate (Pi) and ATP peaks were identified by 
a time-domain fitting routine using the 
AMARES-MRUI Fortran code and using 
appropriate prior knowledge [33]. Signal areas 
were corrected for magnetic saturation effects 
using fully relaxed spectra collected at rest with a 
repetition time of 20 s. Intracellular pH (pHi) was 
calculated from the chemical shift of the Pi signal 
relative to PCr [34]. Time-points for the time 
course of pHi and phosphorylated metabolite 
concentrations were assigned to the midpoints of 
the acquisition intervals. 
 
Statistical analysis 
Unless otherwise stated, data were pooled over 
the animals within the same group, and are 
presented as means ± SEM. Significance of the 
differences between WT and KO animals was 
assessed using Student’s t-test, assuming 
significance at p<0.05. 
NMR variables evolving with respect to time 
during the stimulation period (isometric force 
production, metabolite concentrations, and pHi) 
were analyzed with one-way repeated-
measurements analysis of variance (ANOVA) 
followed by post-hoc Tukey’s tests using JMP 
software (SAS Institute Inc., Cary, NC).  
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Results 
 
Mouse model development: 
In order to delete triadin from skeletal and 
cardiac muscles, we have engineered a triadin 
mouse in which the first exon has been flanked 
by two lox-P sites (figure 1A). After mating 
these "floxed" mice with mice expressing the Cre 
recombinase in the whole animal, we produced a 
triadin null mouse line, in which triadin 
expression has been abolished in all tissues. KO 
(-/-) and WT (+/+) animals were obtained by 
mating heterozygote mice (+/-).The genotype of 
each animal was double-checked by PCR, using 
specific primers (figure 1B). At first sight, KO 
animals were indiscernible from WT animals, 
and the KO mice grew up and reproduced 
normally. Nevertheless, the adult KO animals 
seemed quieter in their cage, which could reflect 
cardiac or skeletal muscles problems. Before 
performing the full physiological 
characterization of the animals, we performed 
molecular controls, in order to evaluate the 
extent of protein modifications induced by 
deletion of triadin gene. We first checked by 
Western blot the absence of all triadins isoforms 
in skeletal as well as in cardiac muscles. We used 
different anti-triadin antibodies, as some react 
with all triadins and some are specific for single 
isoforms. No specific signal was detected with an 
antibody directed against the common N-
terminal end of triadin, either in skeletal muscle 
or in cardiac muscle (figure 1C). In order to 
confirm the absence of all triadin, and 
particularly the expression of proteins truncated 
in the N-terminal end (possibly due to an in 
frame initiation with another ATG), the 
reactivity with specific C-terminal antibodies 
was also assayed (figure 1D). Using a mixture of 
anti-Trisk 95, anti-Trisk 51 and anti-Trisk 32, a 
similar result was observed: no triadin was 
detected in the cardiac and the skeletal muscles 
of the KO animals. These experiments 
demonstrate that the deletion of the first exon in 
triadin gene has indeed led to the production of a 
full triadin KO animal. 
 
Expression levels of the proteins involved in 
calcium homeostasis: 
We used quantitative Western blot to evaluate 
the modification of expression induced by triadin 
suppression in the different proteins involved in 
calcium homeostasis. The expression level of 
RyR, DHPR, SERCA, CSQ, Junctin, and the 
mitochondrial FoF1-ATPsynthase were 
evaluated on EDL and Sol from 3 different WT 
or KO animals of 6-9 months (figure 2). 
Compared to the expression level in WT 
muscles, set to 100% as reference, no 
modification was observed for RyR (125% ± 
35%, p = 0.166 in EDL and 102% ± 17% , p = 
0.295 in Sol), for SERCA (104% ± 5%, p = 0.49 
in EDL and 90% ± 6% p = 0.23 in Sol) and for 
FoF1-ATPase (116% ± 6% p = 0.099 in EDL 
and 94% ± 8%, p = 0.823 in Sol). Junctin was 
not modified in EDL (89%± 12%, p = 0.48), and 
decreased in Sol (55% ± 12%, p = 0.023). An 
important modification was observed for the 
alpha1 subunit of DHPR, which is increased to 
170% ± 14%, p=0.004 in EDL, and reduced in 
Sol (75% ± 7%, p=0.018). The major 
modification concerns CSQ, with a reduction to 
27% ± 4% (p<0.001) in EDL and 19% ± 4% 
(p<0.001) in Sol. Similar results were obtained 
on younger animals (10 weeks) (data not shown). 
DHPR expression was significantly increased in 
EDL (157% ± 18%), and reduced in Sol (81% ± 
5%). CSQ expression was reduced in both 
muscle (56% ± 5% in EDL and 20% ± 2% in 
Sol). The other proteins were not significantly 
modified at 10 weeks. 
 
Influence of triadin deletion on the localization 
of its partners 
Triadin has been shown to interact with RyR and 
CSQ, and was proposed to anchor the luminal 
CSQ at the junctional part of sarcoplasmic 
reticulum, in the triad region [12]. Therefore, 
triadin deletion could result in CSQ 
delocalization, whereas no effect is expected a 
priori on DHPR or RyR localization. In order to 
test this hypothesis, double immunofluorescent 
labelings were performed on dissociated FDB 
fibres of WT or KO animals, using RyR/DHPR 
antibodies or RyR/CSQ antibodies (figure 3). As 
expected, no modification was observed in 
DHPR and RyR localization (figure 3, panels a-f 
and associated quantification graphs), which are 
perfectly colocalized and display the typical 
labeling of the triads in double rows of dots. But, 
CSQ was also perfectly colocalized with RyR, in 
contrast to our initial hypothesis (figure 3, panels 
g-l and associated graphs).  
 
Morphological modifications of KO muscle 
In order to evaluate more precisely the influence 
of triadin deletion on muscle ultrastructure, KO 
and WT muscles were analyzed by electron 
microscopy. No modification was observed in 
soleus (data not shown), whereas in EDL, 
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numbers of triads were in abnormal orientation 
(figure 4), being longitudinal or oblique instead 
of transversal. The abnormal orientation was 
better visualized after T-tubules labeling (fig. 4a 
and c), and the number of triads with 
longitudinal or oblique orientation was evaluated 
to 25% (n=722) in KO instead of 3% (n=680) in 
WT. It is noteworthy that when the triads are 
longitudinally orientated, they usually lose the 
associated mitochondria. At last we observed a 
flattening of the terminal cisternae, which are 
significantly reduced from 68 nm ± 3 nm (n=34) 
to 26 nm ± 1 nm (n=55), as illustrated on figure 
4b and 4e.  
 
Effect of triadin deletion on calcium fluxes 
Calcium imaging studies were performed to 
assess the ability of triadin KO myotubes to 
release calcium after stimulation, and to evaluate 
the amount of calcium releasable upon 
stimulation: the free SR calcium directly released 
after stimulation (which amount is reflected in 
the amplitude of the peak), and the total amount 
of calcium stored (free and CSQ-bound). The 
data are presented on figure 5. Membrane 
depolarization induced by addition of 40mM 
KCl, in the presence of extracellular calcium, 
results in a massive calcium release. The 
amplitude of the peak is slightly but not 
significantly (p=0.14) reduced in triadin KO 
myotubes (fig 5A). The return to basal level is 
significantly slower (p<0.05) in KO compared to 
WT (figure 5A) reflecting either a reduction in 
the reuptake process or an additional intracellular 
influx.  
Direct stimulation of RyR by caffeine was 
performed, either in presence of extracellular 
calcium (fig 5B) or in presence of Cd2+, La3+ to 
block extracellular calcium entry and 
thapsigargin to block SERCA and SR calcium 
reuptake (fig 5C). In the presence of extracellular 
calcium, the maximal amplitude of the calcium 
release is significantly reduced in KO myotubes 
(fig 5B, p=0.002), but the return to basal level is 
identical. This indicates a reduction in the free 
SR calcium rapidly releasable upon stimulation, 
but no modification in the cytosolic calcium 
uptake process. Therefore the effect observed in 
fig 5A (more slowly return to basal level) is most 
probably due to an increased extracellular 
calcium influx via DHPR in correlation with an 
increased expression of the protein.  
When the same experiment was performed while 
preventing Ca2+ influx from extracellular 
medium as well as SR re-uptake using caffeine in 
presence of Cd2+, La3+ and thapsigargin (figure 
5C), the amplitude of the peak was significantly 
reduced in KO (p<0.001), definitively pointing to 
a reduction in the amplitude of the calcium store. 
 
Physiological studies  
To test the overall muscle performance of triadin 
KO mice, the animals were subjected to different 
strength tests, at various ages. They were either 
allowed to freely walk on a wire stretched 
between two rods or hung gripping a cross-wired 
surface with all four paws. KO mice performed 
significantly worse than their WT littermates as 
assessed by the time until they fall. The time 
spent walking the wire was 50 s ± 13 s for the 
WT (n = 5 females, 6 months old) as compared 
to 23 s ± 5 s (n = 6 females, 6 months old) for the 
KO mice (p<0.05). Similar results were obtained 
with the wire grid test, with a hanging time of 
290 s ± 10 s (n=15 animals both sex, 10 weeks 
old) and 45 s ± 12 s (n = 11 animals both sex, 10 
weeks old) (p<0.001) for the WT and KO mice, 
respectively. The weight of the animals had been 
followed during 2 months, and no difference was 
noticed between WT and KO (data not shown). 
The same wire grid test was also performed at 6 
months and gave similar results (data not 
shown). These data suggested that KO mice 
might be weaker than WT mice. 
In order to assay the muscle strength 
independently of any other parameter 
(equilibrium, walking ability, …), muscle 
performance was measured on isolated muscles. 
Fast and slow twitch muscles were dissected 
from the animals, and twitch and tetanic force 
were recorded. Figure 6 presents individual 
traces of twitches (fig. 6A and fig. 6B) and tetani 
(fig. 6D and fig. 6E) from both EDL and Sol of 
WT and KO animals. As depicted in figure 6 
both single twitches and tetani were smaller in 
amplitude for KO than for WT mice. Pooled data 
for the amplitudes of twitches and tetani are 
presented in figures 6C and 6F, respectively. 
Averages present a slightly greater reduction in 
twitch force for Sol as compared to EDL muscles 
in the KO mice. This difference was, however, 
not present for the tetani. Overall, both twitch 
and tetanic forces were significantly reduced in 
fast and slow twitch muscles of KO animals. To 
test how muscles from WT and KO animals 
endure fatigue, series of tetani were applied. 
Figure 7 illustrates the evolution of the maximal 
amplitude of the tetani as normalized to the 
maximal amplitude in a given series. In these 
experiments, the absolute force was always 
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greater in WT than in KO mice. The decline in 
tetanic force was slower for both muscle types in 
KO than in WT animals suggesting a slower 
evolution of fatigue. At the end of the test, the 
maximal force of EDL muscle was 54 % ± 3 % 
of the initial value for WT and 61 % ± 5 % in 
KO mice, and in Sol, it was 48 % ± 3% in WT 
and 61 % ±  4% in KO mice. Nevertheless, even 
at the end of the fatigue run the absolute force 
was not greater in KO than in WT mice (not 
illustrated). Interestingly, the reduction in peak 
tetanic force underwent a slight but sudden drop 
followed by a plateau-like phase early in the run 
giving rise to a shoulder-like part in the data 
measured on KO mice. Such a phenomenon was 
never observed on either EDL or soleus from 
control mice, and could point to a possible 
modification in muscle metabolism.  
 
Gastrocnemius muscle volume and mechanical 
measurements 
In order to confirm the results observed in 
isolated muscle, analyses of muscle morphology, 
function and metabolism were performed using 
NMR combined with muscle contraction. The 
Gastrocnemius muscle was stimulated on an 
anesthetized animal, in order to induce its 
contraction, while 1H and 31P NMR spectra were 
registered. Muscle volume measured using MRI 
(figure 8A) was significantly larger in WT mice 
(109.4 ± 3.3 mm3, n = 9) than in KO mice (92.6 
± 4.3 mm3, n = 9 , p<0.05), but no difference in 
the animal weight was measured (28.6 g ± 1.4g 
for WT versus 26.8 g ± 0.9 g for KO).  
Isometric force production was lower in KO 
mice throughout the whole 6-min stimulation 
protocol (Fig. 8B). For each group, force 
transiently increased in the early stage of the 
stimulation period, to reach a maximal value 
(Fig. 8B). This increase was significantly larger 
in the KO group (+ 40.7 ± 7.0 %) when 
compared to control animals (+ 24.0 ± 3.3 %) 
(Fig. 8C). Afterwards, force decreased 
progressively until the end of the stimulation 
period (Fig. 8B and C). The corresponding 
decrease, measured at the end of the stimulation 
period and illustrating muscle fatigue, was 
smaller in the KO group (85.9 ± 2.4 % of the 
initial value) as compared to controls (57.1 ± 6.0 
% of the initial value) (Fig. 8C). 
 
Energy metabolism 
At rest, PCr/ATP ratio did not differ between 
both groups (Table 1). Basal pHi was similar in 
WT (7.14 ± 0.05) and KO (7.14 ± 0.04) (Fig. 
8D). During the stimulation period, the time-
courses of PCr (Fig. 8D) and pHi (Fig. 8E) were 
similar in both groups. PCr was rapidly 
consumed at the onset of the stimulation period 
and the corresponding initial rates of PCr 
consumption were identical (Table 1). After 2 
minutes of stimulation, PCr reached a steady-
state that was maintained until the end of the 
stimulation period. At that time, PCr levels were 
39.7 ± 3.6 % and 37.4 ± 4.5 % of their basal 
values in WT and KO groups respectively. At the 
onset of the post-stimulation period, the rate of 
PCr resynthesis did not differ between groups 
(Table 1).  
In both groups, pHi, which reflects the anaerobic 
metabolism, fell rapidly in the early stages of the 
stimulation period to reach a steady-state after 3 
minutes of stimulation (Fig. 8E). This steady-
state remained fairly constant until the end of the 
stimulation period, when pHi was 6.74 ± 0.04 in 
WT and 6.77 ± 0.06 in KO animals respectively. 
 
Discussion 
 
Genetic ablation of a protein has been one of the 
most powerful technique used in order to identify 
the precise spectrum of its functions. It has been 
successfully applied to few members of the 
skeletal calcium release complex (RyR1 [35], 
DHPR [36-38], and CSQ1 [39]), to identify 
which precise function could be associated or not 
with each protein. Whereas deletion of RyR 
results in perinatal death, as deletion of the alpha 
1 subunit of DHPR, deletion of CSQ1, that was 
considered as essential, has surprisingly no effect 
on mouse survival or on muscle function [39]. 
Triadin precise function is still unknown, but as 
the triadin gene is expressed in heart, it was 
initially imagined that its deletion would lead to 
embryonic death, as for RyR2 [40]. Surprisingly, 
these mice are viable, as observed in a similar 
triadin KO mouse model recently developed 
[30], and contrary to CSQ KO mice, presented 
important muscle impairment which has been 
characterized in the present work. 
Triadin gene undergoes an important alternative 
splicing, and all the triadins are possibly not 
identified up to now. In order to delete all the 
triadin isoforms, that share at least the 8 first 
exons, we suppressed the first exon from the 
triadin gene. As expected, both in cardiac and 
skeletal muscles of these mice, all known triadin 
isoforms were deleted. Nevertheless, triadin 
suppression affects neither the mouse survival 
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nor its reproduction, as observed in the similar 
model recently reported [30].  
As an adaptative mechanism, the expression 
level of some potential triadin partners, have 
been modified in our triadin KO model. 
Calsequestrin expression level undergoes the 
major modification, confirming the strong 
relationship between triadin and CSQ. The 
present reduction in the CSQ expression level is 
larger than that observed in the triadin KO mouse 
model described previously (4 fold reduction in 
all muscle types in the present work whereas a 
1.5 fold reduction was shown by Shen et al., 
[30]). It is noteworthy that triadin suppression 
did not induce any modification in CSQ triad 
localization. Therefore, if triadin is indeed 
responsible of anchoring CSQ at the terminal 
cisternae of sarcoplasmic reticulum, it is not the 
only protein involved in this function, and most 
probably junctin, which is not modified in this 
triadin KO mouse line, is a good candidate to 
fulfill this function [41]. The important reduction 
in CSQ expression could indicate either that 
triadin is able to regulate CSQ gene expression 
or that defect in CSQ anchoring leads to its 
degradation, as no mislocalization is observed. 
The second protein which expression has been 
surprisingly modified in the present mouse 
model is the alpha1 subunit of DHPR, which is 
overexpressed 1.7 fold in fast (EDL) muscle, but 
not in slow (Soleus) muscle. This is consistent 
with the absence of defects observed in Soleus, 
and it could be hypothesized that longitudinal or 
oblique T-tubules allow the presence of higher 
amount of DHPR. The modification of these two 
proteins is observed at different ages (10 weeks 
and 6 months), but it is more marked at 6 
months, pointing to a possible accentuation of 
the phenotype with aging. This could explain 
why in the model described by Shen et al [30], 
the modifications of the different proteins 
expression were less pronounced, and actually, 
there are no major differences in the expression 
levels of the proteins assessed between the two 
models. The mechanisms leading to DHPR 
overexpression are poorly understood, as no 
direct relationship has been shown between 
DHPR and triadin, and most probably reflect an 
adaptation of the muscle to improve muscle 
function in absence of triadin. 
In agreement with previous results [30], 
ultrastructural analysis on our KO mice revealed 
that 25% of triads have an abnormal orientation. 
Considering the similar results reported in both 
studies, this strongly supports an involvement of 
triadin in the setting up or in the maintenance of 
triad. As for CSQ anchoring, it is mostly 
probable that triadin is not the only protein 
involved in this function. One hypothesis could 
be that triadin would strengthen the triad 
structure, and allow it to be maintained during 
contraction. Further experiments will be needed 
in order to clarify this issue.  
One of our first observations is a muscle 
weakness, in contrast with what has been 
published on the first triadin KO mouse [30], and 
an obvious defect in the time the mice spent on 
the grid of their cage. This prompted us to search 
for objective evaluation of muscle strength. 
Considering that the reduction in the time on the 
grid could induce reduction in the food intake, 
and in animal development, one could expect a 
corresponding weight reduction. No modification 
has been observed on the animal weight, 
therefore the muscle weakness observed in these 
mice does not modify their growth and 
reproduction. A number of tests were performed 
in order to evaluate muscle strength at whole 
animal level. All these tests clearly demonstrated 
a significant muscle strength reduction, at all 
ages assessed, in males as well as in females, and 
this result was further confirmed in isolated 
muscle. Interestingly this muscle weakness is 
accompanied by an improved resistance to 
fatigue, in all muscles tested (EDL, Soleus and 
Gastrocnemius).  
As CSQ's expression is reduced in these muscles, 
could the observed effects be attributed to this 
decrease? It is probably not the case, or only 
partially, because none of the defects observed 
here were similar to defects seen in the CSQ KO 
mouse [39], except for the reduction in terminal 
cisternae thickness which is most probably 
directly related to CSQ reduction. In contrast 
with the CSQ1 KO model, the triadin KO mouse 
showed no increase in RyR, nor in mitochondria 
amount, and no duplication or triplication of 
triad. In addition, no muscle weakness was 
observed in CSQ1 KO mouse, contrary to triadin 
KO mouse. Therefore, the physiological effects 
observed in this KO mouse are clearly different 
from CSQ deletion-induced defects, and can 
clearly be attributed to triadin deletion.  
The muscle weakness observed in triadin KO 
mouse is probably due to reduction of releasable 
calcium observed in primary myotubes upon 
RyR stimulation (either by DHPR or by 
caffeine). This effect was not observed in CSQ1 
KO mouse, which also presented a reduction in 
the calcium store, perhaps because of a 
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compensatory overexpression of RyR and 
mitochondria in this model [39]. The muscle 
weakness could also be attributed to an increase 
in intracellular calcium concentration measured 
in the other triadin KO mouse model [30], but 
this is less probable as in human primary culture, 
a similar intracellular calcium increase has been 
measured associated (Central Core Disease 
patients) or not (Malignant hyperthermia 
susceptible patients) with muscle weakness [42]. 
Therefore, in human muscle culture, the increase 
in intracellular calcium concentration has not 
been correlated to muscle weakness. 
One major common effect observed in both CSQ 
KO and triadin KO is improved resistance to 
fatigue. Fatigue resistance has been shown in a 
number of mice models, and different 
explanations have been proposed. In CSQ1 KO, 
this resistance has been related to an increased 
amount of mitochondria [39], which is not 
observed in our model. In a mouse model KO for 
sarcalumenin [43], another SR calcium binding 
protein of skeletal and cardiac muscle, muscle 
resistance to fatigue has been observed and 
clearly attributed to increased store-operated 
calcium entry (SOCE). This hypothesis could 
most probably be raised for our model, as we 
have previously demonstrated that Trisk 95 
overexpression in rat myotubes resulted in 
decreased SOCE [44]. Therefore, it could be 
hypothesized that triadin deficiency induces a 
reduction in the SR releasable calcium, resulting 
in two compensatory effects: increased DHPR 
expression and an increase in SOCE in order to 
compensate defect in SR calcium release by 
extracellular calcium influx. 
Which function of triadin can then be postulated 
from this model? Triadin is clearly not essential 
for triad formation, as triads are still present. 
Nevertheless, it could be involved in maintaining 
triads during contraction, and in anchoring 
mitochondria close to triads. A precise 
stoechiometry for triadin in the complex is also 
clearly associated with a correct function of the 
calcium release complex. We have previously 
shown that triadin Trisk 95 overexpression 
results in blocking of EC coupling [21], and here 
we show that triadin ablation induced muscle 
function impairment, and modifications in 
depolarization induced calcium release. All these 
results confirm that triadin is an essential link 
within the calcium release complex. The triadin 
KO mouse presents objective muscle 
dysfunctions, and is therefore undoubtedly 
suffering from myopathy as identical energy 
consumption produced a reduced strength. This 
myopathy is a structural myopathy, as the 
observed defect is a modification in the structure 
of the muscle fibre. Mutation in the triadin gene 
in human could probably lead to a myopathy, 
and this gene should be screened in patients 
presenting with a myopathy of unknown origin. 
This mouse line could therefore be a model to 
study the development of a structural myopathy, 
and its evolution during aging and/or exercise. 
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ABBREVIATIONS 
CSQ, Calsequestrin; CT1, Cardiac triadin 1; DHPR, dihydropyridine receptor; E-C coupling, 
excitation-contraction coupling; EDL, Extensor digitorum longus; FDB, Flexor Digitorum Brevis; 
KO, knock out; PCr, phosphocreatine; RyR, ryanodine receptor; SERCA, sarco-endoplasmic 
reticulum Ca2+ ATPase; Sol, soleus; WT, wild type 
 
FIGURES LEGENDS 
 
Figure 1. Molecular characterization of the triadin KO mouse. 
Panel A : Schematic representation of the wild type, floxed and KO allele, and positioning of the 
primers used for the PCR amplification. 
Panel B: PCR amplification of genomic DNA was performed with a mix containing primers A, C and 
D. This gives rise to a band of 240bp on WT animals (+/+, primers C and D), a band of 477bp on KO 
animals (-/-, primers A and D), and both on heterozygotes animals (+/-). The DNA fragment between 
primers A and D is too large to be amplified on WT animals.  
Panel C: Western blot analysis using an anti-N-terminal antibody on WT skeletal muscle (lane 1), KO 
skeletal muscle (lane 2), WT heart (lane 3) and KO heart (lane 4). The signals corresponding to Trisk 
95 (100kDa), Trisk 51 (60kDa) and Trisk 32 (37kDa) was absent in KO muscles (skeletal and 
cardiac). 
Panel D : Western blot analysis using a mix of specific antibodies against Trisk 95, Trisk 51 and Trisk 
32, on WT skeletal muscle (lane 1), KO skeletal muscle (lane 2), WT heart (lane 3) and KO heart (lane 
4). The signals corresponding to Trisk 95 (100kDa), Trisk 51 (60kDa) and Trisk 32 (37kDa) was 
absent in KO muscles (skeletal and cardiac). 
 
Figure 2. Western blot analyzes of EDL and Soleus 
Forty to eighty micrograms of muscle homogenates were loaded on 5-15% polyacrylamide gel. The 
homogenates were prepared using EDL and Soleus (SOL) isolated either from wild type (WT) or 
triadin KO (KO) animal. After electrophoresis separation and Western blot analysis using the 
indicated antibody (RyR, DHPR, SERCA, CSQ, FoF1-ATPase and junctin), the membranes were 
stained with Coomassie blue to evaluate the amount of myosin in each lane, and the signal in Western 
blot was normalized to the amount of myosin. The corresponding quantification is presented on the 
histogram on the right of each blot, the control in each WT condition being set at 100%. 
 
Figure 3.  Double immunofluorescent labelling on isolated muscle fibres 
Muscle fibres were isolated from wild type (WT) or triadin KO (KO) FDB and used to perform double 
immunofluorescent labellings, with antibodies directed against RyR and DHPR (panels a-f) or RyR 
and CSQ (panels g-l). The fluorescence intensity as a function of distance on the fibre was plotted for 
six successive triads, and was reported on the adjacent graph for each labelling. The colour code is 
preserved, and the green curve corresponds to the green immunolabelling, whereas the red curve 
corresponds to the red labelling. Scale bar : 1µm 
 
Figure 4. Electron microscopy analysis of EDL muscle  
EDL were isolated from WT or KO animals, and examined using electron microscopy at different 
magnifications, with (a, c and d) or without tubules labelling (b and e). A number of triads are in 
abnormal orientation in KO muscle (white stars), and presented mainly a longitudinal orientation (c 
and d). The width of the terminal cisternae was measured as shown on pictures b and e, respectively 
on WT and KO muscles. 
 
Figure 5.Calcium imaging in WT or KO cultured myotubes 
Panel A : KCl depolarization (40 mM) was induced in presence of 2 mM external calcium. The left 
curves represent the fluorescence variation in WT (black curve) or KO myotubes (gray curve). The 
histogram on the right presents maximum value ± SEM of fluorescence in control myotubes and in 
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KO myotubes with the number of myotubes tested indicated in each histogram. The asterisk (*) 
indicates statistically significant difference (p<0.05, Student T test). 
Panel B: Caffeine (40mM) was used to directly stimulate RyR in presence of 2mM external calcium. 
The curve and the histogram present respectively the fluorescence variation and the maximum 
fluorescence in WT and KO myotubes. 
Panel C: The same caffeine stimulation was performed in presence of 1µM thapsigargin, 0.5mM Cd2+, 
0.1mM La3+, in WT and KO myotubes, in order to evaluate the amplitude of the calcium store. 
 
Figure 6. Force transients in isolated muscles of wild-type and triadin knock-out mice. Panels A and 
B: Single twitches elicited by short (1 ms), supramaximal (5 V) stimulation on EDL (A) and Soleus 
(B) from WT (continuous line) and KO (dashed line) mice. Panels D and E: Tetani elicited by a train 
of supramaximal stimulation at 200 Hz for 200 ms on EDL (D) and at 100 Hz for 500 ms on Soleus 
(E) from WT (continuous line) and KO (dashed line) mice. Panels C and F: Data were pooled from 5 
WT and 6 KO mice, after averaging the given parameter over each individual record (usually 10) 
measured on an individual muscle. Average amplitude of the twitches (C) and of the tetani (F). 
Asterisks denote significant difference between WT and KO mice (p<0.05).  
Figure 7. Fatigability of wild-type and knock-out mice. Evolution of the amplitude of tetani on EDL 
(A) and Soleus (B). All together 150 tetani (200 and 500 ms long stimulation at 200 and 100 Hz for 
EDL and Soleus, respectively), repeated every 2 s, were evoked on both muscle types and their 
amplitudes normalized to the maximal value in the given train. Measurements were pooled from all 
mice of the given batch to yield the data points presented in the figure. 
 
Figure 8. NMR analysis. (A) NMR image of a hind mouse leg showing delimitation of gastrocnemien.  
(B) Isometric force normalized to muscle volume and (C) relative isometric force during 6 min of 
repeated isometric contractions induced electrically at 1.7 Hz in gastrocnemius. Values are shown as 
means ± SEM. P-value is the result of a one-way repeated-measures ANOVA. * Significant difference 
between both groups for corresponding time points (P < 0.05). (D) Changes in gastrocnemius PCr 
level and (E) intracellular pH during 6 min of repeated isometric contractions induced electrically at 
1.7 Hz. Values are shown as means ± SEM. P-value is the result of a one-way repeated-measures 
ANOVA. The first time point (t = 0) indicates the resting value. 
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Table 1 
 
 
 
Gastrocnemius energy metabolism in WT and KO mice 
 
 WT KO 
Basal PCr/ATP ratio 2.52 ± 0.08 2.48 ± 0.23 
VPCrstim (%.min-1) 67.0 ± 7.9 51.4 ± 7.2 
VPCrrec (%.min-1) 34.6 ± 3.9 30.6 ± 6.1 
 
Values are means ± SEM. VPCrstim, rate of PCr degradation at the start of the 
stimulation period ; VPCrrec, rate of PCr resynthesis at the start of the post-stimulation 
period. 
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Figure 1 
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Figure 2 
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Figure 3 
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Figure 4 
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Figure 5 
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Figure 6 
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Figure 7 
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Figure 8 
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